GALT
Galectin Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
USD2.35
-0.07 (-2.89%)
Rating:C
Company Profile
CEO
Joel Lewis
IPO Date
2002-09-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.43
Prev. Close
$2.42
Day Low
$2.31
Day High
$2.43
52W Low
$1.27
52W High
$7.13
Market Cap
$0.15B
Volume
0.23M